{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:55:05Z","timestamp":1774533305324,"version":"3.50.1"},"reference-count":76,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/j.bulcan.2015.10.009","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T15:03:22Z","timestamp":1447945402000},"page":"1010-1019","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Ost\u00e9on\u00e9crose des maxillaires li\u00e9e aux bisphosphonates et denosumab\u00a0: \u00e9pid\u00e9miologie, diagnostic et traitement"],"prefix":"10.1016","volume":"102","author":[{"given":"Guillaume","family":"Dupic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denise","family":"Collangettes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Fran\u00e7oise","family":"Dillies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laure","family":"Calvet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Tournilhac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques-Olivier","family":"Bay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakim","family":"Mahammedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2015.10.009_bib0385","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1093\/annonc\/mdm442","article-title":"Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel","volume":"19","author":"Aapro","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0390","doi-asserted-by":"crossref","first-page":"192320","DOI":"10.1155\/2014\/192320","article-title":"Bisphosphonate-related osteonecrosis of the jaw: a review of the literature","volume":"2014","author":"Sigua-Rodriguez","year":"2014","journal-title":"Int J Dent"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0395","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.oraloncology.2012.03.028","article-title":"Bisphosphonate-related osteonecrosis of the jaws \u2013 a review","volume":"48","author":"K\u00fchl","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0400","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.critrevonc.2008.10.009","article-title":"Physiopathology and management of osteonecrosis of the jaws related to bisphosphonate therapy for malignant bone lesions. A French expert panel analysis","volume":"71","author":"Tubiana-Hulin","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0405","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","article-title":"Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) Investigators. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure","volume":"68","author":"Lo","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0410","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"International task force on osteonecrosis of the jaw. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0415","series-title":"Ost\u00e9on\u00e9crose des m\u00e2choires en chirurgie oromaxillofaciale et traitements m\u00e9dicamenteux \u00e0 risque (antir\u00e9sorbeurs osseux anti-angiog\u00e9niques), recommandations de bonne pratique","author":"Soci\u00e9t\u00e9 fran\u00e7aise de stomatologie, chirurgie maxillofaciale et chirurgie orale","year":"2013"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0420","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0425","first-page":"48","article-title":"Bisphosphonates et ost\u00e9on\u00e9crose des m\u00e2choires","volume":"53","author":"Pillon","year":"2014","journal-title":"Actual Pharm"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0430","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrrheum.2011.181","article-title":"Epidemiology and pathogenesis of osteonecrosis of the jaw","volume":"8","author":"Reid","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0435","first-page":"2","article-title":"American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws \u2013 2009\u00a0update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0440","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw \u2013 2014\u00a0update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0445","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"American Society for Bone and Mineral Research. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0450","first-page":"1391","article-title":"Canadian Association of Oral and Maxillofacial Surgeons. Canadian consensus practice guidelines for bisphosphonate-associated osteonecrosis of the jaw","volume":"35","author":"Khan","year":"2008","journal-title":"J Rheumatol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0455","series-title":"Recommandations sur la prise en charge bucco-dentaire des patients trait\u00e9s par bisphosphonates","author":"AFSSAPS","year":"2007"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0460","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.oraloncology.2013.06.008","article-title":"Osteonecrosis of the jaw \u2013 prevention and treatment strategies for oral health professionals","volume":"49","author":"Hinchy","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0465","first-page":"413","article-title":"[Osteonecrosis of the jaw and bisphophonates in oncology]","volume":"95","author":"Facon","year":"2008","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0470","first-page":"22","article-title":"Mechanisms of action of bisphosphonates on tumor cells and prospects for use in the treatment of malignant osteolysis","volume":"67","author":"Cl\u00e9zardin","year":"2000","journal-title":"J Bone Spine Rev Rhum"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0475","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1196\/annals.1402.089","article-title":"Bisphosphonates: an update on mechanisms of action and how these relate to clinical efficacy","volume":"1117","author":"Russell","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0480","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0485","first-page":"297","article-title":"[Bisphosphonates as new anticancer agents?]","volume":"102","author":"Robert","year":"2015","journal-title":"Bull Cancer (Paris)"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0490","first-page":"89","article-title":"Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors","volume":"6","author":"Brown-Glaberman","year":"2012","journal-title":"Biol Targets Ther"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0495","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00198-010-1177-6","article-title":"Denosumab-related osteonecrosis of the jaws","volume":"22","author":"Kyrgidis","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0500","first-page":"e1","article-title":"Diagnostic \u00e9tiologique des ost\u00e9on\u00e9croses maxillomandibulaires, ost\u00e9ites \u00e0 bisphosphonates et ost\u00e9oradion\u00e9croses except\u00e9es","volume":"115","author":"Magremanne","year":"2014","journal-title":"Rev Stomatol Chir Maxillofac"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0505","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","article-title":"Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study","volume":"377","author":"Fizazi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0510","first-page":"3707","article-title":"Osteonecrosis of the jaw in patient with denosumab therapy","volume":"7","author":"Olate","year":"2014","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0515","first-page":"3082","article-title":"Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3\u00a0pivotal, randomised, phase 3\u00a0trials","volume":"48","author":"Lipton","year":"2012","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0520","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.amjmed.2008.12.005","article-title":"Osteonecrosis of the jaw and the role of bisphosphonates: a critical review","volume":"122","author":"Silverman","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0525","doi-asserted-by":"crossref","first-page":"471035","DOI":"10.1155\/2014\/471035","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: an update on pathophysiology, risk factors, and treatment","volume":"2014","author":"Rasmusson","year":"2014","journal-title":"Int J Dent"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0530","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.ijom.2012.04.020","article-title":"Use of platelet-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw","volume":"41","author":"Bocanegra-P\u00e9rez","year":"2012","journal-title":"Int J Oral Maxillofac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0535","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.oooo.2014.04.017","article-title":"Bisphosphonate-induced osteonecrosis of the jaws: clinical, imaging, and histopathology findings","volume":"118","author":"Franco-Pretto","year":"2014","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0540","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcms.2011.05.003","article-title":"Bisphosphonate-related osteonecrosis of the jaws \u2013 characteristics, risk factors, clinical features, localization and impact on oncological treatment","volume":"40","author":"Otto","year":"2012","journal-title":"J Cranio-Maxillo-Fac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0545","first-page":"299","article-title":"CONDOR Collaborative Group. Risk factors for osteonecrosis of the jaws: a case-control study from the CONDOR Dental PBRN","volume":"130","author":"Wanrong","year":"2013","journal-title":"Tex Dent J"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0550","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0555","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.080205","article-title":"Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates","volume":"23","author":"Hoff","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0560","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.oooo.2012.05.017","article-title":"Intravenous bisphosphonate-related osteonecrosis of the jaw: long-term follow-up of 109\u00a0patients","volume":"115","author":"Watters","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0565","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/pho.2014.3742","article-title":"Low-level laser therapy supported surgical treatment of bisphosphonate-related osteonecrosis of jaws: a retrospective analysis of 11\u00a0cases","volume":"32","author":"Altay","year":"2014","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0570","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.jcms.2013.11.005","article-title":"Zoledronic acid-related osteonecrosis of the jaws. Experimental model with dental extractions in rats","volume":"42","author":"Barba-Recreo","year":"2014","journal-title":"J Cranio-Maxillo-Fac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0575","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0580","doi-asserted-by":"crossref","first-page":"5356","DOI":"10.1200\/JCO.2009.21.9584","article-title":"Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw","volume":"27","author":"Vahtsevanos","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0585","doi-asserted-by":"crossref","first-page":"981","DOI":"10.14219\/jada.archive.2012.0323","article-title":"Denosumab-related osteonecrosis of the jaw","volume":"143","author":"Diz","year":"2012","journal-title":"J Am Dent Assoc 1939"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0590","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.oraloncology.2011.11.004","article-title":"The saxon bisphosphonate register \u2013 therapy and prevention of bisphosphonate-related osteonecrosis of the jaws","volume":"48","author":"Schubert","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0595","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.bjoms.2009.06.128","article-title":"Management of patients at risk of osteoradionecrosis: results of survey of dentists and oral & maxillofacial surgery units in the United Kingdom, and suggestions for best practice","volume":"48","author":"McLeod","year":"2010","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0600","first-page":"33","article-title":"Bisphosphonate-related osteonecrosis of the jaws: a potential alternative to drug holidays","volume":"61","author":"Damm","year":"2013","journal-title":"Gen Dent"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0605","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.joms.2009.10.026","article-title":"Occurrence of bisphosphonate-related osteonecrosis of the jaw after surgical tooth extraction","volume":"68","author":"Saia","year":"2010","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0610","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00198-012-2239-8","article-title":"Tooth extraction in osteoporotic patients taking oral bisphosphonates","volume":"24","author":"Mozzati","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0615","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.4317\/medoral.18812","article-title":"Case series of 589\u00a0tooth extractions in patients under bisphosphonates therapy. Proposal of a clinical protocol supported by Nd:YAG low-level laser therapy","volume":"18","author":"Vescovi","year":"2013","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0620","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/annonc\/mdn630","article-title":"Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome","volume":"20","author":"Van den Wyngaert","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0625","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.oraloncology.2013.05.012","article-title":"Conservative management of bisphosphonate-related osteonecrosis of the jaws: staging and treatment outcomes","volume":"49","author":"Lerman","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0630","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.oraloncology.2012.07.008","article-title":"Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs)","volume":"49","author":"Holzinger","year":"2013","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0635","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","article-title":"A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)","volume":"50","author":"Rupel","year":"2014","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0640","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.14219\/jada.archive.2011.0108","volume":"142","author":"Hellstein","year":"2011","journal-title":"J Am Dent Assoc 1939"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0645","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.bjoms.2011.08.004","article-title":"Treatment of bisphosphonate-related osteonecrosis of the jaws: presentation of a protocol and an observational longitudinal study of an Italian series of cases","volume":"50","author":"Ferlito","year":"2012","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0650","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jds.2013.03.004","article-title":"Retrospective analysis of 27\u00a0cases of bisphosphonate-related osteonecrosis of the jaw treated surgically or non-surgically","volume":"9","author":"Lu","year":"2014","journal-title":"J Dent Sci"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0655","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.bjoms.2010.09.009","article-title":"Non-surgical management of stage 3\u00a0biphosphonate-related oroantral fistula","volume":"49","author":"Hindawi","year":"2011","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0660","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajoms.2014.02.004","article-title":"Bisphosphonate-related osteonecrosis of the jaw successfully treated with surgical resection and its histopathological features: a long-term follow-up report","volume":"27","author":"Shintani","year":"2015","journal-title":"J Oral Maxillofac Surg Med Pathol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0665","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jcms.2014.01.005","article-title":"Outcomes of osseous free flap reconstruction in stage III bisphosphonate-related osteonecrosis of the jaw: systematic review and a new case series","volume":"42","author":"Vercruysse","year":"2014","journal-title":"J Cranio-Maxillo-Fac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0670","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jcms.2013.05.038","article-title":"Successful surgical management of osteonecrosis of the jaw due to RANK-ligand inhibitor treatment using fluorescence guided bone resection","volume":"41","author":"Otto","year":"2013","journal-title":"J Cranio-Maxillo-Fac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0675","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.tripleo.2007.01.008","article-title":"Biphosphonate-associated osteonecrosis can be controlled by non-surgical management","volume":"104","author":"Montebugnoli","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0680","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jfma.2012.04.010","article-title":"Clinical treatment outcomes for 40\u00a0patients with bisphosphonates-related osteonecrosis of the jaws","volume":"113","author":"Lee","year":"2014","journal-title":"J Formos Med Assoc Taiwan Yi Zhi"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0685","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bjoms.2010.08.005","article-title":"Bisphosphonate osteonecrosis of the jaw: a literature review of UK policies versus international policies on the management of bisphosphonate osteonecrosis of the jaw","volume":"49","author":"McLeod","year":"2011","journal-title":"Br J Oral Maxillofac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0690","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.curtheres.2008.08.003","article-title":"A probable case of oral bisphosphonate-associated osteonecrosis of the jaw and recovery with parathyroid hormone treatment","volume":"69","author":"Song","year":"2008","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0695","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMc1002684","article-title":"Teriparatide therapy for alendronate-associated osteonecrosis of the jaw","volume":"363","author":"Cheung","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0700","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1056\/NEJMc1100730","article-title":"Teriparatide therapy for osteonecrosis of the jaw","volume":"364","author":"Chtioui","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0705","doi-asserted-by":"crossref","first-page":"107690","DOI":"10.1155\/2014\/107690","article-title":"Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw","volume":"2014","author":"Vescovi","year":"2014","journal-title":"Int J Dent"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0710","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.oraloncology.2011.01.002","article-title":"Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: preliminary results of a phase I\u2013II study","volume":"47","author":"Ripamonti","year":"2011","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0715","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1746-160X-7-16","article-title":"Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate-related osteonecrosis of the jaw","volume":"7","author":"Cella","year":"2011","journal-title":"Head Face Med"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0720","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.tripleo.2010.05.067","article-title":"Management of bisphosphonate-associated osteonecrosis: pentoxifylline and tocopherol in addition to antimicrobial therapy. An initial case series","volume":"110","author":"Epstein","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0725","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.joms.2012.04.001","article-title":"What is the role of hyperbaric oxygen in the management of bisphosphonate-related osteonecrosis of the jaw: a randomized controlled trial of hyperbaric oxygen as an adjunct to surgery and antibiotics","volume":"70","author":"Freiberger","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0730","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1038\/bcj.2012.9","article-title":"Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study","volume":"2","author":"Andriani","year":"2012","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0735","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.oraloncology.2011.12.004","article-title":"Platelet-rich therapies in the treatment of intravenous bisphosphonate-related osteonecrosis of the jaw: a report of 32\u00a0cases","volume":"48","author":"Mozzati","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0740","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10103-009-0687-y","article-title":"Surgical approach with Er:YAG laser on osteonecrosis of the jaws (ONJ) in patients under bisphosphonate therapy (BPT)","volume":"25","author":"Vescovi","year":"2010","journal-title":"Lasers Med Sci"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0745","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0714.2011.01091.x","article-title":"Bisphosphonates-related osteonecrosis of the jaws: a concise review of the literature and a report of a single-centre experience with 151\u00a0patients","volume":"41","author":"Vescovi","year":"2012","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0750","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.oraloncology.2011.08.010","article-title":"Association of laser phototherapy with PRP improves healing of bisphosphonate-related osteonecrosis of the jaws in cancer patients: a preliminary study","volume":"48","author":"Martins","year":"2012","journal-title":"Oral Oncol"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0755","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1601-0825.2012.01911.x","article-title":"Non-exposed bisphosphonate-related osteonecrosis of the jaw: a critical assessment of current definition, staging, and treatment guidelines","volume":"18","author":"Patel","year":"2012","journal-title":"Oral Dis"},{"key":"10.1016\/j.bulcan.2015.10.009_bib0760","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1601-0825.2012.01903.x","article-title":"Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"18","author":"Bedogni","year":"2012","journal-title":"Oral Dis"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745511500315X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000745511500315X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T18:15:35Z","timestamp":1567361735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000745511500315X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":76,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S000745511500315X"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.10.009","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ost\u00e9on\u00e9crose des maxillaires li\u00e9e aux bisphosphonates et denosumab\u00a0: \u00e9pid\u00e9miologie, diagnostic et traitement","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2015.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS All rights reserved.","name":"copyright","label":"Copyright"}]}}